A Prospective Cohort Study Assessing the Relationship between Plasma Levels of Osimertinib and Treatment Efficacy and Safety

Osimertinib is a standard treatment for patients with EGFR-mutated non-small cell lung carcinoma (NSCLC). We evaluated the relationship between plasma osimertinib concentrations and treatment outcome in patients with NSCLC for this cohort study. The plasma levels of osimertinib and its metabolite AZ...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukuhara, Tatsuro, Imai, Kazuhiro, Nakagawa, Taku, Igusa, Ryotaro, Yokota, Hayato, Watanabe, Kana, Suzuki, Aya, Morita, Mami, Onodera, Ren, Inoue, Akira, Miura, Masatomo, Minamiya, Yoshihiro, Maemondo, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526408/
https://www.ncbi.nlm.nih.gov/pubmed/37760942
http://dx.doi.org/10.3390/biomedicines11092501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526408/
https://www.ncbi.nlm.nih.gov/pubmed/37760942
http://dx.doi.org/10.3390/biomedicines11092501

Ejemplares similares